Skelton Laurence Matthew
Chief Commercial Officer
Skelton Laurence Matthew has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Feb 25, 2026.
On the most recent filing, Skelton Laurence Matthew is listed as Chief Commercial Officer at Vera Therapeutics, Inc. Inside the rolling window, Skelton Laurence Matthew reported no open-market purchases and 1 open-market sale totaling $66K in VERA.
Companies traded
Other insiders at VERA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$66K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Skelton Laurence Matthew made?
Skelton Laurence Matthew has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Skelton Laurence Matthew trade?
Skelton Laurence Matthew has filed SEC Form 4 disclosures for 1 company, including VERA.
When was Skelton Laurence Matthew's most recent SEC Form 4 filing?
Skelton Laurence Matthew's most recent SEC Form 4 filing on Tracefour is dated Feb 25, 2026.
What is Skelton Laurence Matthew's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Skelton Laurence Matthew is listed as Chief Commercial Officer.
What is Skelton Laurence Matthew's total buy and sell value in the current window?
Inside the rolling retention window, Skelton Laurence Matthew bought $0 and sold $66K based on SEC Form 4 filings.
What was Skelton Laurence Matthew's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,582 VERA shares on 2026-02-23, worth $66K, per SEC Form 4 filings.